Zynex (ZYXI) Competitors $8.07 -0.15 (-1.82%) (As of 12/24/2024 01:48 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZYXI vs. CBLL, LQDA, EYE, BVS, FNA, AXGN, AVNS, IRMD, BFLY, and SMLRShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include CeriBell (CBLL), Liquidia (LQDA), National Vision (EYE), Bioventus (BVS), Paragon 28 (FNA), AxoGen (AXGN), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Zynex vs. CeriBell Liquidia National Vision Bioventus Paragon 28 AxoGen Avanos Medical Iradimed Butterfly Network Semler Scientific CeriBell (NASDAQ:CBLL) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk. Is CBLL or ZYXI more profitable? Zynex has a net margin of 2.49% compared to CeriBell's net margin of 0.00%. Zynex's return on equity of 13.05% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Zynex 2.49%13.05%3.78% Do insiders and institutionals have more ownership in CBLL or ZYXI? 29.7% of Zynex shares are owned by institutional investors. 52.1% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to CBLL or ZYXI? In the previous week, CeriBell and CeriBell both had 2 articles in the media. CeriBell's average media sentiment score of 0.51 beat Zynex's score of 0.17 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zynex 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor CBLL or ZYXI? Zynex received 21 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 58.00% of users gave Zynex an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes8100.00% Underperform VotesNo VotesZynexOutperform Votes2958.00% Underperform Votes2142.00% Which has preferable valuation and earnings, CBLL or ZYXI? Zynex has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$60.04M16.10N/AN/AN/AZynex$193.67M1.33$9.73M$0.1553.80 Do analysts recommend CBLL or ZYXI? CeriBell presently has a consensus price target of $32.60, suggesting a potential upside of 20.83%. Zynex has a consensus price target of $14.00, suggesting a potential upside of 73.48%. Given Zynex's higher probable upside, analysts clearly believe Zynex is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryZynex beats CeriBell on 8 of the 12 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$257.00M$3.09B$5.22B$9.25BDividend YieldN/A1.77%5.12%4.28%P/E Ratio53.8016.8587.5417.27Price / Sales1.3351.841,166.59119.75Price / Cash19.7839.9343.2337.83Price / Book5.933.814.834.93Net Income$9.73M$89.83M$120.46M$225.34M7 Day Performance-1.22%5.51%2.85%4.14%1 Month Performance-3.24%-0.07%19.70%1.15%1 Year Performance-24.15%2.11%30.57%16.98% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex3.5409 of 5 stars$8.07-1.8%$14.00+73.5%-24.2%$257.00M$193.67M53.801,100CBLLCeriBellN/A$27.01+0.3%$32.60+20.7%N/A$967.61M$60.04M0.00N/ANews CoverageLQDALiquidia3.3311 of 5 stars$11.33+2.1%$25.38+124.0%-2.0%$958.94M$15.61M-6.9550EYENational Vision3.7332 of 5 stars$11.13-3.8%$14.00+25.8%-44.7%$876.49M$2.18B-55.6513,998Positive NewsBVSBioventus3.2892 of 5 stars$10.58-0.8%$15.00+41.8%+104.2%$858.62M$555.06M-17.341,200FNAParagon 283.1152 of 5 stars$10.14+1.1%$15.60+53.8%-17.6%$848.92M$245.00M-13.70343,000AXGNAxoGen1.1869 of 5 stars$16.76+7.2%$15.00-10.5%+132.3%$737.57M$180.86M-52.38426News CoveragePositive NewsGap UpAVNSAvanos Medical2.7216 of 5 stars$15.94-0.9%N/A-29.7%$732.56M$681.50M46.883,771Negative NewsIRMDIradimed4.5307 of 5 stars$53.88-1.4%$60.00+11.4%+17.0%$682.82M$71.31M36.90110BFLYButterfly Network0.6133 of 5 stars$3.05-1.3%$3.00-1.6%+193.4%$649.84M$76.22M-6.63460SMLRSemler Scientific1.3024 of 5 stars$60.10-2.7%N/A+65.0%$556.95M$58.94M29.3292 Related Companies and Tools Related Companies CeriBell Alternatives Liquidia Alternatives National Vision Alternatives Bioventus Alternatives Paragon 28 Alternatives AxoGen Alternatives Avanos Medical Alternatives Iradimed Alternatives Butterfly Network Alternatives Semler Scientific Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZYXI) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZYXI Stock Alerts